AI Healthcare Regulations in Alaska (2025 Guide)

Alaska has no standalone AI healthcare law yet, but HCR 3 creates a task force. Learn what rules apply now, what's changing, and who to contact.

Alaska has no standalone AI healthcare law as of mid-2025. Existing rules (HIPAA, the Alaska Medical Practice Act, and federal FDA frameworks) apply. HCR 3 from the 34th Legislature proposes a task force, signaling formal rulemaking is coming.

Quick Answer: Does Alaska Have AI Healthcare Regulations?

No, Alaska has not enacted a statute that specifically regulates artificial intelligence in healthcare. As of mid-2025, there is no Alaska law requiring algorithmic bias audits, mandatory patient disclosure when AI is used in clinical decisions, or AI-specific licensing for healthcare software vendors.

The use of AI in healthcare is still governed by three layers of existing law:

Alaska state law covers the licensed professionals who use AI tools (Alaska Stat. § 08.64, the Medical Practice Act), the health records those tools touch (Alaska Stat. § 18.23), and deceptive marketing of health products (Alaska Stat. § 45.50.471). None of these statutes mention AI by name, but they apply when AI is the mechanism through which a violation occurs.

Federal law addresses larger regulatory areas. HIPAA (45 CFR Parts 160 and 164) governs any AI vendor handling protected health information. The FDA's Software as a Medical Device framework governs AI tools that meet the definition of a medical device. Section 5 of the FTC Act (15 U.S.C. § 45) reaches deceptive claims about AI diagnostic accuracy.

Legislative activity is beginning. HCR 3 (34th Alaska Legislature) proposes establishing a Joint Legislative Task Force on Artificial Intelligence. The resolution's subject tags include privacy, science and technology, business, and economic development, placing healthcare AI within its scope. Task force findings could lead to binding legislation in the 35th Legislature (2026-2027 session).

For compliance teams, this means auditing AI tools against existing HIPAA, FDA SaMD, and Alaska professional licensing requirements. Monitor the output of the proposed HCR 3 task force, but do not wait for a standalone Alaska AI healthcare statute before ensuring compliance with current law.

Applicable Alaska Statutes and Regulations for Healthcare AI

Medical Practice Act (Alaska Stat. § 08.64)

Alaska's Medical Practice Act governs the clinical conduct of licensed physicians and other providers. When a provider uses an AI clinical decision-support tool, the Act's scope-of-practice and standard-of-care obligations still apply to the provider. The Alaska State Medical Board has authority under Alaska Stat. § 08.64.336 to discipline licensees for unprofessional conduct, which could include uncritical reliance on an AI tool that produces a harmful recommendation. Consult the Alaska State Medical Board directly for current guidance on AI in clinical practice.

Health Records and Privacy (Alaska Stat. § 18.23)

Alaska Stat. § 18.23 governs health information and medical records. AI vendors that train models on Alaska patient data or process records must ensure their data handling practices are consistent with this statute and HIPAA. Alaska does not have a separate biometric or health data privacy law that would impose additional consent or deletion requirements on AI training data. Consult the Alaska Department of Health if a use case involves risk of re-identifying de-identified data.

Consumer Protection Act (Alaska Stat. § 45.50.471)

The Alaska Consumer Protection Act prohibits unfair or deceptive trade practices. AI health product vendors making unsubstantiated claims about diagnostic accuracy, clinical efficacy, or FDA clearance status face liability under this statute, in addition to federal FTC Act liability. The Alaska Attorney General's Consumer Protection Unit enforces this provision.

Health Records and Vital Statistics (Alaska Stat. § 18.05)

Alaska Stat. § 18.05 governs vital statistics and official health records. AI-generated clinical documentation, including ambient scribing outputs that become part of the official medical record, must meet the same accuracy and authentication standards as human-authored records. Providers should confirm their EHR vendor's AI documentation tools comply with record integrity requirements.

Telehealth (Alaska Stat. § 21.07.250)

Alaska's telehealth statute permits synchronous and asynchronous care delivery. AI-assisted telehealth platforms, including AI triage chatbots, operate under this framework. The statute does not specifically address AI, but the standard-of-care obligations for the supervising provider remain unchanged.

Division of Insurance (3 AAC 26)

Alaska Division of Insurance regulations under 3 AAC 26 govern health insurance practices. AI-driven claims adjudication and underwriting tools used by Alaska-licensed insurers fall under existing unfair trade practices and claims handling rules. Consult the Alaska Division of Insurance directly for current guidance on AI in health insurance and to determine if it has adopted or follows the NAIC Model Bulletin on the Use of Artificial Intelligence Systems by Insurers.

HCR 3 and the Joint Legislative Task Force on AI: What It Means for Healthcare

What HCR 3 Proposes

A House Concurrent Resolution is not a statute. HCR 3 (34th Alaska Legislature) does not create enforceable legal obligations or impose penalties. It proposes the creation of a Joint Legislative Task Force on Artificial Intelligence, giving that body a mandate to study AI's implications and report back to the Legislature. For the resolution to take effect, both chambers of the Legislature must adopt it. Confirm the bill's current status with the Alaska Legislature's bill tracking system.

Task Force Scope

The resolution's subject tags (privacy, science and technology, business, and economic development) define the task force's scope broadly enough to include healthcare AI. The task force is expected to examine:

Patient data privacy implications of AI-driven clinical tools
AI use in health insurance underwriting and claims
Liability allocation when AI contributes to a clinical error
Algorithmic bias and health equity concerns

How to Participate

Stakeholders can engage through the Alaska Legislature's public testimony process. Written testimony can be submitted to the relevant House and Senate committees during scheduled hearings. Monitor the Alaska Legislature's website (legis.alaska.gov) for hearing notices. The task force itself may hold public meetings, which would be posted on the Legislature's committee calendar.

Expected Timeline

If the task force is established and completes its work during the 34th Legislature, its findings could be introduced as binding legislation in the 35th Legislature (2026-2027 session). Other states have followed a similar path from study to statute. Alaska stakeholders should view the 2025-2026 period as the window to shape future rules.

Federal AI Healthcare Rules That Apply in Alaska

FDA Software as a Medical Device (SaMD)

The FDA's SaMD framework determines whether an AI clinical tool requires premarket clearance as a medical device under 21 U.S.C. § 321(h). AI diagnostic imaging tools that analyze images to detect pathology almost always qualify. AI clinical decision-support tools may qualify depending on whether they are intended to replace or merely inform clinical judgment.

Tools requiring clearance must go through 510(k) or De Novo authorization (21 CFR Part 880). The FDA's AI/ML action plan includes predetermined change control plans, which allow cleared AI tools to update their algorithms within pre-approved parameters without a new submission. Healthcare organizations procuring AI clinical tools should verify FDA clearance status before deployment.

HIPAA Business Associate Requirements

Any AI vendor that accesses, processes, or stores protected health information (PHI) on behalf of a covered entity is a business associate under HIPAA (45 CFR § 164.308; 45 CFR § 164.502). A signed Business Associate Agreement is required before the vendor can access PHI. The HHS Office for Civil Rights actively enforces this requirement.

FTC Act Section 5

The FTC Act (15 U.S.C. § 45) prohibits unfair or deceptive acts in commerce. AI health product vendors that overstate diagnostic accuracy, imply FDA clearance they do not have, or make unsupported clinical efficacy claims face FTC enforcement.

ADA Title III

AI tools used in patient-facing settings, such as triage chatbots and scheduling systems, must not discriminate against patients with disabilities. Title III of the Americans with Disabilities Act applies to healthcare facilities and their digital interfaces. AI tools that systematically deprioritize patients based on disability-correlated inputs create ADA liability.

ONC HTI-1 Rule

The ONC Health Data, Technology, and Interoperability Final Rule (HTI-1, 88 Fed. Reg. 23746, 2023) strengthens information blocking prohibitions. AI tools that restrict access to or export of patient data may trigger information blocking liability under 45 CFR Part 171. Consult the Alaska Department of Health for current state Medicaid interoperability requirements.

CMS Conditions of Participation

CMS surveys of hospitals and other certified providers examine clinical decision support tools, including AI-driven ones, as part of quality and patient safety reviews. Facilities should document how AI tools are validated, monitored, and overridden when clinically appropriate.

What Changed Recently: Alaska AI Regulatory Activity (2024-2025)

HCR 3 introduction (2025): This is the first formal Alaska legislative action specifically addressing artificial intelligence, marking a shift toward active legislative engagement.

Cosponsor activity (2025): The addition of cosponsors to HCR 3 indicates growing legislative support. Verify the current cosponsor list with the Alaska Legislature's bill tracking system.

Alaska Division of Insurance: Consult the Division directly to confirm that no AI-specific bulletins on health insurance underwriting or claims adjudication have been issued.

Alaska State Medical Board: Consult the Board directly to confirm that no formal advisory opinion or published guidance on AI clinical decision support has been issued.

Federal actions with Alaska impact: HHS released an updated Artificial Intelligence Strategy in 2024. CMS also issued guidance in 2024 on AI use in Medicare Advantage prior authorization, requiring that AI not be the sole basis for coverage determinations. These federal actions apply to Alaska Medicare Advantage plans and providers.

What is not yet in place in Alaska: No enacted AI liability framework, algorithmic bias audit requirement, mandatory patient disclosure rule for AI use in clinical decisions, or AI-specific state-level registration requirements.

Compliance Comparison: Key Requirements by Healthcare AI Use Case in Alaska

AI Use Case	Applicable Alaska Rule	Applicable Federal Rule	Current Alaska Status	Risk Level
AI diagnostic imaging tool	Alaska Stat. § 08.64 (provider liability)	FDA SaMD guidance; 21 CFR Part 880; HIPAA 45 CFR § 164.308	No Alaska-specific rule; FDA clearance is primary gate	High — FDA enforcement active
AI clinical decision support in EHR	Alaska Stat. § 08.64 (scope of practice)	FDA SaMD guidance; CMS CoP surveys; HIPAA BAA required	No Alaska-specific rule; provider standard of care applies	High — Proposed HCR 3 task force likely to address
AI chatbot for patient triage	Alaska Stat. § 45.50.471 (deceptive claims); AS 21.07.250 if telehealth-adjacent	FTC Act 15 U.S.C. § 45; ADA Title III; HIPAA if PHI collected	No Alaska-specific rule	Medium-High — FTC and ADA exposure
AI-driven insurance claims review	3 AAC 26 (unfair claims practices)	CMS Medicare Advantage AI guidance (2024); HIPAA 45 CFR § 164.502	No Alaska AI-specific bulletin confirmed; existing claims rules apply	Medium — NAIC model bulletin adoption status pending
AI ambient documentation/scribing	Alaska Stat. § 18.05 (record integrity); Alaska Stat. § 18.23	HIPAA BAA required; ONC HTI-1 (88 Fed. Reg. 23746)	No Alaska-specific rule; record authentication standards apply	Medium — Growing use, limited guidance
AI in telehealth platforms	Alaska Stat. § 21.07.250; Alaska Stat. § 08.64	FDA SaMD if diagnostic function; HIPAA; FTC Act	Telehealth statute silent on AI; provider obligations unchanged	Medium — Proposed HCR 3 task force likely to address

Alaska does not charge AI-specific permit fees or require AI-specific state registration for healthcare software vendors. Standard business and professional licensing requirements apply.

Next Steps and Who to Contact in Alaska

For Healthcare Providers

Contact the Alaska State Medical Board regarding expectations for AI tool disclosure and documentation. The Board's authority derives from Alaska Stat. § 08.64.336. Reach the Board through the Alaska Division of Corporations, Business and Professional Licensing at commerce.alaska.gov/web/cbpl/ProfessionalLicensing/MedicalBoard.aspx or (907) 465-2541.

For AI Vendors

Execute HIPAA Business Associate Agreements with all covered entity partners before accessing PHI (45 CFR § 164.308). Confirm FDA SaMD classification for any tool with a clinical decision function. Monitor the FDA's predetermined change control plan guidance for adaptive algorithms. Register for updates from the FDA's Digital Health Center of Excellence at fda.gov/digital-health.

For Insurers

Contact the Alaska Division of Insurance for guidance on AI use in underwriting and claims. The Division operates under AS 21.06 and can be reached at commerce.alaska.gov/web/ins or (907) 465-2515. Ask whether the Division has issued guidance consistent with the NAIC Model Bulletin on AI in Insurance.

For Legislative Engagement

Submit written testimony on HCR 3 through the Alaska Legislature's public testimony process at legis.alaska.gov. Monitor House and Senate committee calendars for hearings. If the Joint Legislative Task Force on AI is formed and holds public meetings, they will be posted on the Legislature's committee schedule.

For Patients

To file a complaint, use one of two pathways. For state-level concerns, contact the Alaska Department of Health (health.alaska.gov). For concerns about health information misuse, file a HIPAA complaint with the HHS Office for Civil Rights at hhs.gov/ocr/complaints or 1-800-368-1019 (45 CFR § 160.306).

Recommended Monitoring

Subscribe to the Alaska Legislature's bill tracker at legis.alaska.gov for HCR 3 updates. Subscribe to FDA Digital Health updates and HHS AI strategy releases. Check Alaska Division of Insurance bulletins quarterly.

While Alaska lacks a specific AI statute, existing state and federal frameworks create significant enforcement risk. Consult legal counsel with experience in Alaska health law and FDA regulations before deploying clinical AI tools.